• Member News

Innovate UK funding for new precision cancer treatment technology

Sixfold Bioscience and Medicines Discovery Catapult awarded Innovate UK grant to pursue ground-breaking project

ARECOR TO PRESENT AT EASD 2020 - ORAL PRESENTATION OF PHASE I CLINICAL TRIAL OF AT247, A NOVEL ULTRA RAPID ACTING INSULIN

Arecor Limited. the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its abstract titled ‘Phase I study investigating the PD, PK and safety of AT247 in comparison to insulin aspart, NovoRapid®, and fast insulin aspart, Fiasp®, has been selected for oral presentation at the upcoming European Association for the Study of Diabetes (EASD) virtual meeting which will be held from 21-25 September 2020. Abstract #55 is available online.

Accelerate@Babraham Start-up Programme underway with four new life science start-ups taking part in the five month programme

Benefits of the programme include access to the Babraham Research Campus bio-incubator facilities, an extended programme of mentoring and support and £10k undiluted funding

Growth continues at Discovery Park as new tenants arrive

Psyros Diagnostics & VisusNano join innovation community

Abzena announced as best CRO at World ADC awards

Cambridge, UK and San Diego, CA, 17th September 2020 – Abzena, a fully integrated global development and GMP manufacturing partner for the biopharmaceutical industry, has been announced as the winner of the Best Contract Research (CRO) category at the World ADC Awards 2020.   

Mogrify wins Life Science Innovation Award and Prof. Julian Gough named Academic Entrepreneur of the Year at Business Weekly Awards 2020

• Mogrify recognized for furthering life science discovery for the benefit of human healthcare through direct cellular conversion technology • Co-founder and CSO receives award celebrating his achievements in establishing Mogrify

CTI Clinical Trial and Consulting Services Announces Acquisition of Middle East/Northern African based Clinart

CTI announces the acquisition of Clinart, a full-service contract research organization with strong local expertise in the Middle East and Northern Africa (MENA) region.

VisusNano opens new facility at Discovery Park and receives additional Innovate UK funding to accelerate revolutionary intraocular lens technology

Medtech company VisusNano announces the opening of its 800 sq. ft facility at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing companies.

Cytiva launches Xcellerex Automated Perfusion System for more efficient manufacture of biotherapeutics

Cytiva introduces the Xcellerex Automated Perfusion System (APS), an innovation to the market that supports the biotech industry’s move to continuous manufacturing.

CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsy

The extensive and advanced work to develop the critical analytical assays needed for quality control in the manufacture of the AAV1 based gene therapy product CG01 has now been completed in a collaboration between CombiGene and CGT Catapult. CombiGene will now integrate the analytical assays into its production process, taking it another step closer to its final large scale production design for clinical trials and commercial distribution.